Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Harper Molly
Over the trailing 90 days, Harper Molly (Director at CATALYST PHARMACEUTICALS, INC.) sold $116K of stock in CPRX, per 10 SEC Form 4 transactions.
- Role
- Director
- Companies
- CPRX
- Window
- Trailing 90 days · 10 transactions · CIK 1871470
- Net activity
- −$116K ($0 bought · $116K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | 10 | — | $116K | −$116K |
Transactions (10)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-15 | CPRX | Sell | 15.0K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 20.0K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 12.5K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 18.1K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 5.5K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 3.7K | $116K | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 1.9K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 1.4K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 23.2K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-15 | CPRX | Sell | 29.5K | $0 | Disposition to the issuer of issuer equity securities |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Harper's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.